Author:
Rosell Rafael,González-Cao María,Molina-Vila Miguel Angel
Reference10 articles.
1. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma;Scafoglio;Sci Transl Med,2018
2. Lung cancer in patients who have never smoked—an emerging disease;LoPiccolo;Nat Rev Clin Oncol,2024
3. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial;de Langen;Lancet,2023
4. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial;Han;Lancet Respir Med,2024
5. Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis;Kästner;Lancet Reg Health Eur,2023